Journal
FOOD RESEARCH INTERNATIONAL
Volume 38, Issue 10, Pages 1117-1123Publisher
ELSEVIER
DOI: 10.1016/j.foodres.2005.03.006
Keywords
eggs; docosahexaenoic acid; humans; statin; cholesterol; omega-3 polyunsaturated fatty acids; serum phospholipid
Categories
Ask authors/readers for more resources
The purpose of this study was to investigate the effects of consuming a novel docosahexaenoic acid (DHA)-enriched shell egg on the serum lipid levels and omega - 3 polyunsaturated fatty acids (n - 3 PUFA) of serum phospholipid in statin-treated hypercholesterol-emic patients. Fifteen subjects were randomly divided into two treatment groups and consumed either two control or two novel DHA-enriched eggs during two organized breakfast periods of 21 consecutive days each using a double-blinded, cross-over design. The novel enriched eggs from feeding the specialty ration provided 217 mg of DHA and 629 mg of total n - 3 PUFA per day. Total serum cholesterol levels were unchanged with either egg consumption and no significant alterations in lipid levels were found due to a treatment effect. The novel egg group exhibited a significant rise in eicosapentaenoic acid (EPA) plus DHA levels in serum phospholipid (by 23%) which can be related to a reduced risk for fatal ischemic heart disease. Consumption of this novel egg offers an alternative food option for more than doubling current sub-optimal DHA intakes in North America. (c) 2005 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available